Research ExplorerPublicationsTransapical mitral valve-in-ring procedure with a novel self...

Transapical mitral valve-in-ring procedure with a novel self-expandable transcatheter heart valve: first- and last-in-man report

Standard

Transapical mitral valve-in-ring procedure with a novel self-expandable transcatheter heart valve: first- and last-in-man report. / Schaefer, Andreas; Seiffert, Moritz; Blankenberg, Stefan; Conradi, Lenard.

In: EUR J CARDIO-THORAC, Vol. 58, No. 1, 01.07.2020, p. 190-192.

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Harvard

Schaefer, A, Seiffert, M, Blankenberg, S & Conradi, L 2020, 'Transapical mitral valve-in-ring procedure with a novel self-expandable transcatheter heart valve: first- and last-in-man report', EUR J CARDIO-THORAC, vol. 58, no. 1, pp. 190-192. https://doi.org/10.1093/ejcts/ezz350

APA

Schaefer, A., Seiffert, M., Blankenberg, S., & Conradi, L. (2020). Transapical mitral valve-in-ring procedure with a novel self-expandable transcatheter heart valve: first- and last-in-man report. EUR J CARDIO-THORAC, 58(1), 190-192. https://doi.org/10.1093/ejcts/ezz350

Vancouver

Schaefer A, Seiffert M, Blankenberg S, Conradi L. Transapical mitral valve-in-ring procedure with a novel self-expandable transcatheter heart valve: first- and last-in-man report. EUR J CARDIO-THORAC. 2020 Jul 1;58(1):190-192. https://doi.org/10.1093/ejcts/ezz350

Bibtex

@article{4980b1cfa59d4498b5579cc68455f7df,
title = "Transapical mitral valve-in-ring procedure with a novel self-expandable transcatheter heart valve: first- and last-in-man report",
abstract = "Interventional therapy of failing surgical mitral valve replacement and repair is an appealing option in patients who are not eligible for redo surgery. We herein report on the first-in-human use of a repositionable, self-expandable transcatheter heart valve with motorized delivery for a transapical mitral valve-in-ring procedure. After implantation, fluoroscopy showed no residual regurgitation and pressure measurements did not reveal any signs of left ventricular outflow tract obstruction.",
keywords = "Cardiac Catheterization, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve/diagnostic imaging, Mitral Valve Insufficiency/diagnostic imaging, Prosthesis Design, Treatment Outcome",
author = "Andreas Schaefer and Moritz Seiffert and Stefan Blankenberg and Lenard Conradi",
note = "{\textcopyright} The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.",
year = "2020",
month = jul,
day = "1",
doi = "10.1093/ejcts/ezz350",
language = "English",
volume = "58",
pages = "190--192",
journal = "EUR J CARDIO-THORAC",
issn = "1010-7940",
publisher = "Elsevier",
number = "1",

}

RIS

TY - JOUR

T1 - Transapical mitral valve-in-ring procedure with a novel self-expandable transcatheter heart valve: first- and last-in-man report

AU - Schaefer, Andreas

AU - Seiffert, Moritz

AU - Blankenberg, Stefan

AU - Conradi, Lenard

N1 - © The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

PY - 2020/7/1

Y1 - 2020/7/1

N2 - Interventional therapy of failing surgical mitral valve replacement and repair is an appealing option in patients who are not eligible for redo surgery. We herein report on the first-in-human use of a repositionable, self-expandable transcatheter heart valve with motorized delivery for a transapical mitral valve-in-ring procedure. After implantation, fluoroscopy showed no residual regurgitation and pressure measurements did not reveal any signs of left ventricular outflow tract obstruction.

AB - Interventional therapy of failing surgical mitral valve replacement and repair is an appealing option in patients who are not eligible for redo surgery. We herein report on the first-in-human use of a repositionable, self-expandable transcatheter heart valve with motorized delivery for a transapical mitral valve-in-ring procedure. After implantation, fluoroscopy showed no residual regurgitation and pressure measurements did not reveal any signs of left ventricular outflow tract obstruction.

KW - Cardiac Catheterization

KW - Heart Valve Prosthesis

KW - Heart Valve Prosthesis Implantation/adverse effects

KW - Humans

KW - Mitral Valve/diagnostic imaging

KW - Mitral Valve Insufficiency/diagnostic imaging

KW - Prosthesis Design

KW - Treatment Outcome

U2 - 10.1093/ejcts/ezz350

DO - 10.1093/ejcts/ezz350

M3 - Other (editorial matter etc.)

C2 - 31860025

VL - 58

SP - 190

EP - 192

JO - EUR J CARDIO-THORAC

JF - EUR J CARDIO-THORAC

SN - 1010-7940

IS - 1

ER -